Welcome!

News Feed Item

Understanding and Tackling Prostate and Colorectal Cancer Through Unlocking the Cancer's DNA Code

LEIDEN, The Netherlands, February 27, 2014 /PRNewswire/ --

With a large contribution of the Center for Translational Molecular Medicine (CTMM), a new Dutch consortium will study the relationship between DNA aberrations and the development of both prostate and colorectal tumours. The project application has been filed by the Erasmus Medical Center, ServiceXS B.V. and the VU University Medical Center and will be coordinated by professor Guido Jenster (Erasmus MC). They have received funding of 1 million euros for this project called "NGS-ProToCol".

Cancer and DNA

Cancer is a disease of the DNA, caused by changes in the genome of normal cells, resulting in cancer cells with the ability to continuously grow and to respond variably on anticancer treatments. In order to understand why normal cells become cancer cells and how we can identify and destroy them, the researchers in this project want to uncover all the DNA changes in a large set of individual tumors. Particularly for common tumor types such as prostate and colorectal cancers the researchers hope to make a serious impact and improve diagnosis, prognosis and treatment.

Recent developments in the area of genome sequencing (also called next-generation sequencing) make it possible to discover all mutations in a tumour in a single experiment. By analyzing the genome and transcriptome of multiple prostate and colorectal tumours, the researchers expect to discover and validate markers useful for finding tumors in an early stage and for predicting the aggressiveness of the disease. In addition, the genomic information will result in the identification of novel cancer proteins for which new therapeutic drugs can be designed.

Website: http://www.ctmm.nl/en/projecten/translational-research-it-trait/ngs-protocol


Background information NGS ProToCol

The study project has been named NGS-ProToCol and aligns well with the expertise and the ambitions of the Erasmus MC and VUmc in the field of cancer research and that of ServiceXS in the area of genome and transcriptome analyses. The researchers at the Erasmus MC will study in prostate tumours how DNA mutations will influence the nature of the tumour, whereas VUmc will perform similar analyses in colorectal tumours. Being a pioneer in the area of genome sequencing, ServiceXS will perform the DNA and RNA sequencing experiments. The researchers expect to be able to come with results within 2 years.

NGS-ProToCol extends the genomic work initiated by two other CTMM projects: Prostate Cancer Molecular Medicine (PCMM; coordinated by Prof. dr. Chris Bangma, Erasmus MC) and Decrease Colorectal cancer Death (DeCoDe; coordinated by Prof. dr. Gerrit Meijer, VUmc). Within these consortia, DNA and RNA analyses already identified candidate biomarkers that with next-generation sequencing technologies will be validated in NGS-ProToCol. In addition, the challenging and complex workflows for NGS data management and data processing will be captured and made publicly available through a third CTMM project, TRAnslational research IT (TraIT; coordinated by Prof. dr. Gerrit Meijer, VUmc).    

About CTMM

The CTMM (Center for Translational Molecular Medicine) is a Netherlands-based public-private partnership. It is dedicated to the development of technologies in molecular medicine that enable early diagnosis and personalized treatment for main areas of disease causing mortality and diminished quality of life in the western world. Focus lies on oncology, cardiovascular, neurodegenerative and infectious/auto-immune disease. CTMM operates by inviting, assessing and funding multidisciplinary projects that involve active participation by Netherlands-based academia and industry. All CTMM projects are judged by an independent International Advisory Board and approved by a Supervisory Board based on their significant potential to translate research knowledge into clinical practice. The CTMM is funded by the Dutch government (50%), academia (25%) and industry (25%). Additional funding is provided by supporting foundations on behalf of patients.

Key figures CTMM: 122 partners, M€ 302.7 allocated budget until the end of 2015, 25 projects/consortia

http://www.ctmm.nl

About Erasmus MC and VUmc

As centres of medical innovation, the Erasmus Medical Center (Erasmus MC) and VU University Medical Center (VUmc) play an (inter)nationally recognized leading role in cancer research. The core tasks of the both centers are research, education, patient care and training. Both hospitals are part of the Dutch Federation of University Medical Centers (NFU). The NFU is a cooperation of the eight University Medical Centers in the Netherlands.

http://www.erasmusmc.nl

http://www.vumc.nl

About ServiceXS B.V.

ServiceXS is a service company in the area of molecular genetics and is based in Leiden, The Netherlands. In 2006 ServiceXS was the first company in Europe to offer next-generation sequencing services. Recently, ServiceXS was the first service provider world-wide to acquire Ion-Proton equipment, which offers new possibilities for whole-genome genetic analysis and will be used for this first Dutch large-scale cancer genetics project.

http://www.servicexs.com

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that Keisoku Research Consultant Co. will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Keisoku Research Consultant, Co. offers research and consulting in a wide range of civil engineering-related fields from information construction to preservation of cultural properties. For more information, vi...
The last two years has seen discussions about cloud computing evolve from the public / private / hybrid split to the reality that most enterprises will be creating a complex, multi-cloud strategy. Companies are wary of committing all of their resources to a single cloud, and instead are choosing to spread the risk – and the benefits – of cloud computing across multiple providers and internal infrastructures, as they follow their business needs. Will this approach be successful? How large is the ...
Kubernetes is an open source system for automating deployment, scaling, and management of containerized applications. Kubernetes was originally built by Google, leveraging years of experience with managing container workloads, and is now a Cloud Native Compute Foundation (CNCF) project. Kubernetes has been widely adopted by the community, supported on all major public and private cloud providers, and is gaining rapid adoption in enterprises. However, Kubernetes may seem intimidating and complex ...
SYS-CON Events announced today that B2Cloud will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. B2Cloud specializes in IoT devices for preventive and predictive maintenance in any kind of equipment retrieving data like Energy consumption, working time, temperature, humidity, pressure, etc.
SYS-CON Events announced today that N3N will exhibit at SYS-CON's @ThingsExpo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. N3N’s solutions increase the effectiveness of operations and control centers, increase the value of IoT investments, and facilitate real-time operational decision making. N3N enables operations teams with a four dimensional digital “big board” that consolidates real-time live video feeds alongside IoT sensor data a...
SYS-CON Events announced today that Daiya Industry will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Daiya Industry specializes in orthotic support systems and assistive devices with pneumatic artificial muscles in order to contribute to an extended healthy life expectancy. For more information, please visit https://www.daiyak...
SYS-CON Events announced today that Interface Corporation will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Interface Corporation is a company developing, manufacturing and marketing high quality and wide variety of industrial computers and interface modules such as PCIs and PCI express. For more information, visit http://www.i...
SYS-CON Events announced today that Mobile Create USA will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Mobile Create USA Inc. is an MVNO-based business model that uses portable communication devices and cellular-based infrastructure in the development, sales, operation and mobile communications systems incorporating GPS capabi...
In his session at @ThingsExpo, Greg Gorman is the Director, IoT Developer Ecosystem, Watson IoT, will provide a short tutorial on Node-RED, a Node.js-based programming tool for wiring together hardware devices, APIs and online services in new and interesting ways. It provides a browser-based editor that makes it easy to wire together flows using a wide range of nodes in the palette that can be deployed to its runtime in a single-click. There is a large library of contributed nodes that help so...
Elon Musk is among the notable industry figures who worries about the power of AI to destroy rather than help society. Mark Zuckerberg, on the other hand, embraces all that is going on. AI is most powerful when deployed across the vast networks being built for Internets of Things in the manufacturing, transportation and logistics, retail, healthcare, government and other sectors. Is AI transforming IoT for the good or the bad? Do we need to worry about its potential destructive power? Or will we...
New competitors, disruptive technologies, and growing expectations are pushing every business to both adopt and deliver new digital services. This ‘Digital Transformation’ demands rapid delivery and continuous iteration of new competitive services via multiple channels, which in turn demands new service delivery techniques – including DevOps. In this power panel at @DevOpsSummit 20th Cloud Expo, moderated by DevOps Conference Co-Chair Andi Mann, panelists examined how DevOps helps to meet the de...
Cloud Expo, Inc. has announced today that Andi Mann and Aruna Ravichandran have been named Co-Chairs of @DevOpsSummit at Cloud Expo Silicon Valley which will take place Oct. 31-Nov. 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. "DevOps is at the intersection of technology and business-optimizing tools, organizations and processes to bring measurable improvements in productivity and profitability," said Aruna Ravichandran, vice president, DevOps product and solutions marketing...
21st International Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Me...
SYS-CON Events announced today that mruby Forum will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. mruby is the lightweight implementation of the Ruby language. We introduce mruby and the mruby IoT framework that enhances development productivity. For more information, visit http://forum.mruby.org/.
SYS-CON Events announced today that Suzuki Inc. will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Suzuki Inc. is a semiconductor-related business, including sales of consuming parts, parts repair, and maintenance for semiconductor manufacturing machines, etc. It is also a health care business providing experimental research for...